Oxford Biodynamics (OBD) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Dec 2016 09:31 AM
RNS
Holding(s) in Company
08 Dec 2016 09:29 AM
RNS
Holding(s) in Company
06 Dec 2016 07:00 AM
RNS
Admission to AIM and First Day of Dealings

Oxford Biodynamics' international store for clinical smart tests and research kits based on pioneering EpiSwitch® 3D genomic technology.

OBD was spun out of Oxford University in 2007 to commercialize blood tests based on 3D Genomics research. OBD's tests are designed to help people make informed health decisions and reduce healthcare costs.

OBD share price launched at 162p in 2016.

UK 100

Latest directors dealings